Hepatitis B, Chronic

Publication Title: 
Yonsei Medical Journal

PURPOSE: The purpose of this study was to investigate the influence of chronic virus- related liver disease severity on propofol requirements. MATERIALS AND METHODS: In this study, 48 male patients with chronic hepatitis B infection were divided into three groups according to Child-Turcotte-Pugh classification of liver function (groups A, B, and C with mild, moderate and severe liver disease, respectively). After intubation, propofol concentration was adjusted by ± 0.3 ?g/mL increments to maintain bispectral index in the range of 40-60.

Author(s): 
Wu, Jian
Huang, Su-Qin
Chen, Qing-Lian
Zheng, Shu-Sen
Publication Title: 
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
Author(s): 
Tu, Yan-yun
Qiu, Hai-xian
Publication Title: 
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
Author(s): 
Chen, Li
He, Zhi-yi
He, Shan-ming
Zhang, Ling
Huang, Bin
Tu, Yuan-yun
Zhang, Hong-xing
Jiang, Yang-kun
Li, Yi-zhong
Publication Title: 
Journal of Korean Academy of Nursing

PURPOSE: This ethnograpy was done to explore patterns of health care behavior in patients with chronic health problems. METHODS: The participants were 15 patients with chronic hepatitis B and 2 family members. Among the patients 4 had progressed to liver cirrhosis and liver cancer. Data were collected from iterative fieldwork in a department of internal medicine of I hospital. Data were analyzed using text analysis and taxonomic methods.

Author(s): 
Yang, Jin-Hyang
Cho, Myung-Ok
Lee, Hae-Ok
Publication Title: 
Zhong Xi Yi Jie He Xue Bao = Journal of Chinese Integrative Medicine

This paper summarized the effects of the treatment of chronic hepatitis B (CHB) by lamivudine combined with traditional Chinese medicine or western medicine in the past few years. Combined treatment of lamivudine and the other medicine had higher efficiency than lamvudine alone in the treatment of CHB. The Combined treatment should be a tendency of the treatment for chronic hepatitis B. The focal point is that the traditional Chinese recipe produces a multitarget effect in the treatment of CHB.

Author(s): 
Chen, Tao
Chen, Wen-Hui
Publication Title: 
World journal of gastroenterology: WJG

AIM: This study aims at exploring the distribution of TCM syndromes in CHB patients with HBV pre-core mutation (1896) and the relationship between pre-core mutation and T lymphocytes subgroup, through which to provide objective data on clinical syndrome differentiation of TCM, and further to suggest the therapeutic principle and guide clinical treatment. METHODS: One hundred and forty CHB patients were evenly divided into two study groups, HBV pre-core mutant group and HBV pre-core wild-type group. Besides, 30 healthy blood donors were selected as a healthy control group.

Author(s): 
Yang, Hong-Zhi
Zhao, Jian-An
Dai, Min
Li, Yong-Wei
Wang, Yong-Ze
Guan, Wei-Bing
Xie, He-Ping
Publication Title: 
Hepatobiliary & pancreatic diseases international: HBPD INT

BACKGROUND: Although resection is the major treatment for patients with hepatocellular carcinoma (HCC), the high intrahepatic recurrence remains a cardinal cause of death. This study was undertaken to evaluate the effect of hepatic arterial infusion chemotherapy on the survival and recurrence of HCC patients with hepatitis B virus (HBV) cirrhosis after resection. METHODS: Twenty-eight patients who had undergone placement of a hepatic arterial pump at the time of liver wedge resection for HCC from 1998 through 2004 were reviewed retrospectively.

Author(s): 
Wen, Jun
Shen, Wen-Lv
Yang, Shao-Hua
Publication Title: 
Zhong Xi Yi Jie He Xue Bao = Journal of Chinese Integrative Medicine

Deficiency of Qi (healthy energy) and blood stasis are the basic pathological changes of hepatic fibrosis according to the theories of traditional Chinese medicine. Fuzheng Huayu Capsule, a compound Chinese herbal medicine for hepatic fibrosis, is produced in the light of this pathological mechanism. More than a decade of clinical studies and experimental researches show that this medicine has effects of protecting hepatic cells, relieving liver injury, and controlling the development of hepatic fibrosis. It has definite functional mechanisms on anti-hepatic fibrosis.

Author(s): 
Zhao, Chang-Qing
Wu, Yi-Qing
Xu, Lie-Ming
Publication Title: 
Alimentary Pharmacology & Therapeutics

BACKGROUND: Safety of traditional Chinese medicine in patients with chronic hepatitis B is unknown. AIM: To study the clinical outcome of traditional Chinese medicine-induced hepatotoxicity in chronic hepatitis B patients. PATIENTS AND METHODS: All chronic hepatitis B patients in 2004 with liver dysfunction requiring hospitalization were screened prospectively for traditional Chinese medicine intake. The hepatotoxicity of individual traditional Chinese medicine elements was determined by extensive search of both English and Chinese publications.

Author(s): 
Yuen, M.-F.
Tam, S.
Fung, J.
Wong, D. K.-H.
Wong, B. C.-Y.
Lai, C.-L.
Publication Title: 
Zhong Xi Yi Jie He Xue Bao = Journal of Chinese Integrative Medicine

OBJECTIVE: A method based on dubious condition of information entropy was introduced and applied to discuss a complexity problem in the analysis of correlation between traditional Chinese medicine (TCM) syndrome and season. METHODS: Eight hundred and seventy one cases of chronic virus hepatitis B (hepatitis B) with TCM clinical data were analyzed by information entropy method. RESULTS: It was found that hepatitis B with Yin deficiency of liver and kidney happened more often in summer than in other seasons.

Author(s): 
Sun, Ji-Jia
Jiang, Jian
Zhu, Lei-lei
Gao, Yue-Qiu
Yan, Guang-le
Su, Shi-Bing

Pages

Subscribe to RSS - Hepatitis B, Chronic